Nicholas Ngiam

36PUBLICATIONS
26CO-AUTHORS
Medical bacteriologyPredictive and prognostic markersMedical infection agents (incl. prions)CryptographyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 23, 2026
Clinical presentation and outcomes in non-maltophilia Stenotrophomonas spp. bloodstream infections.

|Jun 03, 2026
Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

|Apr 10, 2026
Recurrent Campylobacter jejuni bacteraemia with independent acquisition of carbapenem resistance in three ST9611 isolates: a case series in immunocompromised hosts.

Jinghao Nicholas Ngiam, Matthew Chung Yi Koh, Grace Tung

|Sep 29, 2025
Clinical characteristics and treatment outcomes of Acinetobacter baumannii bloodstream infections in a setting with high carbapenem susceptibility among isolates.

Jinghao Nicholas Ngiam, Matthew Chung Yi Koh, Ka Lip Chew

|Jul 28, 2025
Cefepime Versus Carbapenem Therapy for the Treatment of Invasive Infections With Inducible Chromosomal AmpC-Producing Enterobacterales: A Systematic Review and Meta-analysis.

Hao Min Cheo, Darren Yan Kit Ho, Lin Pin Koh

|Jun 13, 2025
Can ChatGPT Counter Vaccine Hesitancy? An Evaluation of ChatGPT's Responses to Simulated Queries from the General Public.

Matthew Chung Yi Koh, Jinghao Nicholas Ngiam, Brenda Mae Alferez Salada

Pageof 6

Frequent Collaborators

13 joint publications

Matthew Chung Yi Koh

6 joint publications

Paul Anatharajah Tambyah

4 joint publications

Nicholas Ws Chew

3 joint publications

Ching-Hui Sia